Heavy alcohol consumption and an unhealthy diet prior to a diagnosis of gastric cancer can affect treatment outcomes, a new study shows.
Researchers evaluated the addition of the AKT inhibitor ipatasertib to mFOLFOX6 for patients with gastric cancer.
Watch this PracticeUpdate video for an overview of gastric cancer treatments (register for free to view).
Dr. Syma Iqbal, Keck School of Medicine at University of Southern California, discusses second- and third-line therapies in gastric cancer via OncLive.
Watch this new video on the implications of fibroblast growth factor (FGF) 2 amplification for GI Cancer Treatment.